231 related articles for article (PubMed ID: 26240252)
1. Private payers disagree with Medicare over medical device coverage about half the time.
Chambers JD; Chenoweth M; Thorat T; Neumann PJ
Health Aff (Millwood); 2015 Aug; 34(8):1376-82. PubMed ID: 26240252
[TBL] [Abstract][Full Text] [Related]
2. Medicare is scrutinizing evidence more tightly for national coverage determinations.
Chambers JD; Chenoweth M; Cangelosi MJ; Pyo J; Cohen JT; Neumann PJ
Health Aff (Millwood); 2015 Feb; 34(2):253-60. PubMed ID: 25646105
[TBL] [Abstract][Full Text] [Related]
3. Medicare's national coverage decisions for technologies, 1999-2007.
Neumann PJ; Kamae MS; Palmer JA
Health Aff (Millwood); 2008; 27(6):1620-31. PubMed ID: 18997221
[TBL] [Abstract][Full Text] [Related]
4. CHANGING FACE OF MEDICARE'S NATIONAL COVERAGE DETERMINATIONS FOR TECHNOLOGY.
Chambers JD; Chenoweth MD; Pyo J; Cangelosi MJ; Neumann PJ
Int J Technol Assess Health Care; 2015 Jan; 31(5):347-54. PubMed ID: 26750558
[TBL] [Abstract][Full Text] [Related]
5. Mapping US commercial payers' coverage policies for medical interventions.
Chambers JD; Chenoweth MD; Neumann PJ
Am J Manag Care; 2016 Sep; 22(9):e323-8. PubMed ID: 27662396
[TBL] [Abstract][Full Text] [Related]
6. Medicare's national coverage determinations in diagnostic radiology: examining evidence and setting limits.
Otero HJ; Chambers JD; Bresnahan BW; Kamae MS; Yucel KE; Neumann PJ
Acad Radiol; 2012 Sep; 19(9):1060-5. PubMed ID: 22748382
[TBL] [Abstract][Full Text] [Related]
7. Costs and spillover effects of private insurers' coverage of hepatitis C treatment.
Moreno GA; Mulligan K; Huber C; Linthicum MT; Dreyfus D; Juday T; Marx SE; Gonzalez YS; Brookmeyer R; Lakdawalla DN
Am J Manag Care; 2016 May; 22(6 Spec No.):SP236-44. PubMed ID: 27266954
[TBL] [Abstract][Full Text] [Related]
8. Medicare program: review of national coverage determinations and local coverage determinations. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2003 Nov; 68(216):63691-731. PubMed ID: 14610762
[TBL] [Abstract][Full Text] [Related]
9. Variation in Private Payer Coverage of Rheumatoid Arthritis Drugs.
Chambers JD; Wilkinson CL; Anderson JE; Chenoweth MD
J Manag Care Spec Pharm; 2016 Oct; 22(10):1176-81. PubMed ID: 27668566
[TBL] [Abstract][Full Text] [Related]
10. Local medical review policies.
Bryant N
Issue Brief Cent Medicare Educ; 2004; 5(1):1-6. PubMed ID: 15002463
[TBL] [Abstract][Full Text] [Related]
11. Value-based interventional pain management: a review of medicare national and local coverage determination policies.
Manchikanti L; Falco FJ; Benyamin RM; Helm S; Singh V; Hirsch JA
Pain Physician; 2013; 16(3):E145-80. PubMed ID: 23703416
[TBL] [Abstract][Full Text] [Related]
12. Strengthening Multipayer Collaboration: Lessons From the Comprehensive Primary Care Initiative.
Anglin G; Tu HA; Liao K; Sessums L; Taylor EF
Milbank Q; 2017 Sep; 95(3):602-633. PubMed ID: 28895218
[TBL] [Abstract][Full Text] [Related]
13. Who pays when VA users are hospitalized in the private sector? Evidence from three data sources.
West AN; Weeks WB
Med Care; 2007 Oct; 45(10):1003-7. PubMed ID: 17890999
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based coverage policy.
Garber AM
Health Aff (Millwood); 2001; 20(5):62-82. PubMed ID: 11558722
[TBL] [Abstract][Full Text] [Related]
15. Variation in Medicaid and commercial payer coverage of aducanumab for Alzheimer's disease.
Lin PJ; Levine A; Rucker J; Chambers JD
Alzheimers Dement; 2023 Aug; 19(8):3654-3669. PubMed ID: 36852834
[TBL] [Abstract][Full Text] [Related]
16. Forcing isolation: Medicare's "in the home" coverage standard for wheelchairs.
Medicare Rights Center
Care Manag J; 2005; 6(1):29-37. PubMed ID: 16447855
[TBL] [Abstract][Full Text] [Related]
17. Financing home health-care products and services.
Curtiss FR
Am J Hosp Pharm; 1986 Jan; 43(1):121-31. PubMed ID: 3082192
[TBL] [Abstract][Full Text] [Related]
18. Using clinical trials as a condition of coverage: lessons from the National Emphysema Treatment Trial.
Carino T; Sheingold S; Tunis S
Clin Trials; 2004 Feb; 1(1):108-14; discussion 115-21. PubMed ID: 16281466
[TBL] [Abstract][Full Text] [Related]
19. Role of technology assessment in health benefits coverage for medical devices.
Braslow NM; Shatin D; McCarthy DB; Newcomer LN
Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
[TBL] [Abstract][Full Text] [Related]
20. Authority of Medicare to Limit Coverage of FDA-Approved Products: Legal and Policy Considerations.
Daval CJR; Kesselheim AS
JAMA Intern Med; 2023 Sep; 183(9):999-1004. PubMed ID: 37505487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
